Non-invasive method and apparatus for diagnosing and monitoring aortic valve abnormalities, such as aortic regurgitation
AssigneePulse Metric, Inc.
InventorsShiu-Shin Chio, Todd Brinton
Life of this patent
Estimating the term…
Loading patent…
AssigneePulse Metric, Inc.
InventorsShiu-Shin Chio, Todd Brinton
Estimating the term…
A method and device is provided for determining aortic valve abnormalities. The method first includes the step of providing a sphygmomanometer device for inducing a pressure on a body part of a patient. A data stream receiver is provided for receiving a stream of data relating to the pressure response of the pulsed fluid flowing through the cardiovascular system of the patient. A data processor is provided for processing the data to create a series of time dependant pulse wave forms. The data can be converted by Fast Fourier Transformation (FFT) to obtain Power Spectrum (PS) which comprises a frequency dependant array of pulse signals. Both of the time dependant and frequency dependant (Power Spectrum) data can be displayed and analyzed to help determine the condition of the aortic valve and the percentage of regurgitation of the patient. With the Power Spectrum display, the determination is made based on first, identifying the existence of an additional second series of harmonically occurring regurgitation signals that have a frequency different from the main signals indicative of the forward flow of fluid through the aortic valve. The ratio of the amplitude or density of the regurgitation signal peak can be divided by the amplitude or density of the associated main signal peak, to determine the ratio of the associated “Regurgitation” flow to and “Main” flow, to thereby semi-quantitatively determine the percent of regurgitation flow of the patient.
A method for identifying the existence of aortic valve abnormalities in a patient comprising the steps of:
A method for identifying the existence of aortic valve abnormalities, comprising the steps of:
A device for identifying the existence of aortic valve abnormalities in a patient comprising:
A device for identifying the existence of aortic valve abnormalities, comprising:
A method for identifying the existence of aortic valve abnormalities in a patient wherein the patient employs a non-invasive pressure inducer for inducing a pressure on a body part of the patient by applying pressure to the body part, and generating a stream of pulsation signal data relating to the pressure response of pulsed fluid flowing through the cardiovascular system of the patient, the method comprising the steps of:
A method for identifying the existence of aortic valve abnormalities in a patient wherein the patient employs a non-invasive pressure inducer for inducing a pressure on a body part of the patient, and who exerts a pressure on the body part, thereby generating a stream of pulsation signal data relating to the pressure response of pulsed pressure flowing through the cardiovascular system of the patient, the method comprising the steps of:
A device for identifying the existence of aortic valve abnormalities in a patient wherein a non-invasive pressure inducer has been employed for applying a pressure to a body part and for generating a stream of pulsation signal data relating to the pressure response of pulsed fluid flowing through the cardiovascular system of the patient, the device comprising:
A device for identifying the existence of aortic valve abnormalities in a patient wherein a non-invasive pressure inducer has been employed for applying a pressure to a body part of the patient, and for generating a stream of pulsation signal data relating to the pressure response of pulsed fluid flowing through the cardiovascular system of the patient, the device comprising:
Dependencies are inferred from the claim text.